Brief: Niagen Bioscience To Streamline Operations With The Sale Of Chromadex Reference Standards Business To LGC
26/02/2026 12:28
Feb 26 (Reuters) - Niagen Bioscience Inc NAGE.O: NIAGEN BIOSCIENCE TO STREAMLINE AND FOCUS ITS OPERATIONS WITH THE SALE OF CHROMADEX REFERENCE STANDARDS BUSINESS TO LGC IN ALL-CASH TRANSACTION NIAGEN BIOSCIENCE INC - SELLS CHROMADEX BUSINESS TO LGC IN ALL-CASH DEAL Source text: ID:nBw8CrN2na Further company coverage: NAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce